AstraZeneca Plc’s 2007 earnings were down 3 percent, the company said.
Its pretax profit was 7.98 billion dollars as sales were 12 percent up.
AstraZeneca said that market conditions remained challenging but cost-cutting would improve profits this year.
AstraZeneca PLC is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the merger of Swedish Astra AB and British Zeneca Group PLC.
Zeneca was part of Imperial Chemical Industries prior to a demerger in 1993. AstraZeneca develops, manufactures, and sells pharmaceuticals to treat disorders in the gastrointestinal, cardiac and vascular, neurological and psychiatric, infection, respiratory, pathological inflammation and oncology areas.
Russian military repeatedly thwarted Turkey's attempts to deploy its troops to Syria, and stopped militants from moving further south